Symposium: Plenary Speakers

Patrick Anquetil, Portal Instruments

Natalie Artzi, MIT/Brigham and Women’s Hospital

Henry Brem, Johns Hopkins University

Hongming Chen, Kala Pharmaceuticals

Mark E. Davis, California Institute of Technology

Joseph DeSimone, Carbon/ University of North Carolina

Douglas Eby, Vivtex Corporation

Hideyoshi Harashima, Hokkaido University

Adrian Hepner, Eagle Therapeutics

Yosuke Hiraoka, Nitta Gelatin, Inc

Ian Hunter, Portal Instruments

Masaru Ishii, Osaka University

Lloyd Johnston, Selecta Biosciences

Hiroshi Kikuchi, LTT Bio-Pharma Co, Ltd.

Joachim Kohn, Rutgers University

Ryo Kojima, Astellas Pharma, Inc.

David Lucchino, Frequency Therapeutics, Inc.

Hidetoshi Masumoto, Kyoto University

Yasuhiro Matsumura, EPOC National Cancer Center

Chad Mirkin, Northwestern University

Samir Mitragotri, Harvard University

Masaya Nakamura, Keio University School of Medicine

Tatiana Novobrantseva, Verseau Pharmaceuticals

Takahiro Ochiya, Tokyo Medical University

John Patton, Dance Pharmaceuticals

David Pernock, Eagle Therapeutics

Mark Prausnitz, Georgia Institute of Technology

Shinsuke Sando, University of Tokyo

Katsuto Tamai, Osaka University

Giovanni Traverso, MIT/Brigham and Women’s Hospital

Rogerio Vivaldi, Sigilon Therapeutics

Thomas von Erlach, Vivtex Corporation

Chae-Ok Yun, Hanyang University